References
- Arnold GL, Beaves MR, Pryjdun VO, Mook WJ. (2002). Preliminary study of ciprofloxacin in active Crohn’s disease. Inflamm Bowel Dis 8:10–15
- Biswal I, Dinda A, Das D, et al. (2011). Encapsulation protocol for highly hydrophilic drug using non-biodegradable polymer. Int J Pharm Sci 3:256–9
- Chong-Kook K, Mi-Jung K, Kyoung-Hee O. (1994). Preparation and evaluation of sustained release microspheres of terbutaline sulfate. Int J Pharm 106:213–19
- Coco R, Plapied L, Pourcelle V, et al. (2013). Drug delivery to inflamed colon by nanoparticles: comparison of different strategies. Int J Pharm 440:3–12
- Collnot E-M, Ali H, Lehr C-M. (2012). Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release 161:235–46
- Esposito E, Cervellati F, Menegatti E, et al. (2002). Spray dried Eudragit microparticles as encapsulation devices for vitamin C. Int J Pharm 242:329–34
- Esposito E, Roncarati R, Cortesi R, et al. (2000). Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics. Pharm Dev Technol 5:267–78
- Fahmy S, Abu-Gharbieh E. (2014). In vitro dissolution and in vivo bioavailability of six brands of ciprofloxacin tablets administered in rabbits and their pharmacokinetic modeling. BioMed Res Int 2014, 1–8. doi:10.1155/2014/590848
- Greenbloom SL, Steinhart AH, Greenberg GR. (1998). Combination ciprofloxacin and metronidazole for active Crohn’s disease. Can J Gastroenterol 12:53–6
- Harder S, Fuhr U, Beermann D, Staib A. (1990). Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. Br J Clin Pharmacol 30:35–9
- He P, Davis SS, Illum L. (1999). Chitosan microspheres prepared by spray drying. Int J Pharma 187:53–65
- Khan MK, Khan MF. (2005). Extraction and separation of ciprofloxacin by HPLC from human plasma. Intl Chem Pharm Med 2:267–70
- Kim C-K, Mi-Jung K, Kyoung-Hee O. (1994). Preparation and evaluation of sustained release microspheres of terbutaline sulfate. Int J Pharm 106:213–19
- Lal S, Steinhart AH. (2006). Antibiotic therapy for Crohn’s disease: a review. Can J Gastroenterol 20:651–5
- Lamprecht A, Schäfer U, Lehr, C.-M. (2001). Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 18:788–93
- Lautenschläger C, Schmidt C, Fischer D, Stallmach A. (2014). Drug delivery strategies in the therapy of inflammatory bowel disease. Adv Drug Deliv Rev 71:58–76
- Lorenzo-Lamosa ML, Remuñán-López C, Vila-Jato JL, Alonso MJ. (1998). Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release 52:109–18
- Makhlof A, Tozuka Y, Takeuchi H. (2009). pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Für Pharm Verfahrenstechnik EV 72:1–8
- Otsuka M, Onoe M, Matsuda Y. (1993). Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with eudragit. J Pharm Sci 82:32–8
- Padhy SK, Sahoo D, Acharya D, Mallick J. (2013). Formulation and in-vitro evaluation of ciprofloxacin hydrochloride sustained release tablets using various viscosity grades of hydroxypropyl methylcellulose. Am J Pharm Tech Res 3:1433–43
- Prantera C, Berto E, Scribano ML, Falasco G. (1998). Use of antibiotics in the treatment of active Crohn’s disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 30:602–6
- Prantera C, Zannoni F, Scribano ML, et al. (1996). An antibiotic regimen for the treatment of active Crohn’s disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91:328–32
- Rahman MM, Roy S, Das SC, et al. n.d. Formulation and evaluation of hydroxypropylmethylcellulose based matrix systems as oral sustained release drug delivery systems for ciprofloxacin hydrochoride. Int J Pharmaceut Sci Rev Res 6:34–41
- Reddy RB, Malleswari K, Prasad G, Pavani G. (2013). Colon targeted drug delivery system: a review. IJPSR 4:42–54
- Richardson JF, Backhurst J, Harker JH. (2002). Chemical engineering. Vol. 2. San Diego (CA): Butterworth-Heinemann [Imprint] Elsevier Science & Technology Books
- Ruan L-P, Chen S, Yu B-Y, et al. (2006). Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem 41:605–10
- Schmidt C, Lautenschlaeger C, Collnot E-M, et al. (2013). Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa - a first in vivo study in human patients. J Control Release 165:139–45
- Shishu Kamalpreet, Maheshwari M. (2012). Development and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using non-everted rat intestine sac model. Drug Dev Ind Pharm 38:294–300
- Singh, Jagpreet Singh, Daisy Sharma, Anil Sharma. (2012). Colon specific drug delivery system: review on novel approaches. IJPSR 3:637–47
- Steinhart AH, Feagan BG, Wong CJ, et al. (2002). Combined budesonide and antibiotic therapy for active Crohn’s disease: a randomized controlled trial. Gastroenterology 123:33–40
- Verma S, Vipin Kumar V, Mishra DN, Singh SK. (2012). Colon targeted drug delivery: current and novel perspectives. IJPSR 3:1274–84
- Vinay KG, Gnanarajan G, Preeti Kothiyal. (2012). A review article on colonic targeted drug delivery system 1:14–24
- Vivian S, José Ramón H, Carlos P. (2007). Las microesferas como sistemas de liberación controlada de péptidos y proteínas
- Wu S-S, Chein C-Y, Wen Y-H. (2008). Analysis of ciprofloxacin by a simple high-performance liquid chromatography method. J Chromatogr Sci 46:490–5